GIORGI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 10.779
AS - Asia 6.026
EU - Europa 4.598
SA - Sud America 587
AF - Africa 219
Continente sconosciuto - Info sul continente non disponibili 75
OC - Oceania 11
Totale 22.295
Nazione #
US - Stati Uniti d'America 10.396
CN - Cina 1.798
SG - Singapore 1.587
IT - Italia 1.517
VN - Vietnam 793
SE - Svezia 732
HK - Hong Kong 701
DE - Germania 582
BR - Brasile 517
BG - Bulgaria 338
KR - Corea 321
GB - Regno Unito 305
CA - Canada 295
TR - Turchia 267
FR - Francia 212
UA - Ucraina 201
FI - Finlandia 185
IN - India 171
RU - Federazione Russa 162
CH - Svizzera 134
JP - Giappone 103
CI - Costa d'Avorio 78
BD - Bangladesh 60
GR - Grecia 56
AT - Austria 43
NG - Nigeria 38
IQ - Iraq 36
BE - Belgio 32
MX - Messico 32
IR - Iran 23
PK - Pakistan 23
ZA - Sudafrica 23
SN - Senegal 22
ID - Indonesia 21
PL - Polonia 21
SA - Arabia Saudita 21
AR - Argentina 20
NL - Olanda 20
MA - Marocco 14
UZ - Uzbekistan 13
VE - Venezuela 13
CR - Costa Rica 12
EC - Ecuador 12
ES - Italia 12
JM - Giamaica 11
EU - Europa 9
KZ - Kazakistan 9
AU - Australia 8
NP - Nepal 8
EG - Egitto 7
IE - Irlanda 7
KE - Kenya 7
OM - Oman 7
PH - Filippine 7
CO - Colombia 6
HN - Honduras 6
JO - Giordania 6
KG - Kirghizistan 6
LT - Lituania 6
MY - Malesia 6
TW - Taiwan 6
BB - Barbados 5
BJ - Benin 5
CG - Congo 5
CL - Cile 5
DZ - Algeria 5
HU - Ungheria 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
DK - Danimarca 4
ET - Etiopia 4
PY - Paraguay 4
YE - Yemen 4
BH - Bahrain 3
CY - Cipro 3
EE - Estonia 3
GT - Guatemala 3
IL - Israele 3
LB - Libano 3
PE - Perù 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
IS - Islanda 2
KN - Saint Kitts e Nevis 2
LC - Santa Lucia 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
Totale 22.200
Città #
Woodbridge 1.171
Ann Arbor 1.007
Ashburn 943
Singapore 889
Houston 772
Milan 758
Chandler 700
Hong Kong 681
Santa Clara 573
San Jose 488
Hefei 434
Fairfield 426
Dong Ket 391
Beijing 351
Sofia 338
Dallas 315
Seoul 291
Council Bluffs 252
Jacksonville 242
Shanghai 229
Ottawa 206
Wilmington 203
New York 176
Seattle 175
Los Angeles 174
Chicago 173
Cambridge 172
Izmir 172
Boardman 133
Princeton 127
Lawrence 117
Ho Chi Minh City 113
Medford 111
Nanjing 109
Lauterbourg 101
Hanoi 94
Bern 93
Tokyo 93
Abidjan 78
Des Moines 66
Jüchen 63
London 62
Rome 57
Alessandria 56
Buffalo 56
Serra 55
Dearborn 53
The Dalles 52
Florence 51
Columbus 49
São Paulo 49
Istanbul 47
Helsinki 42
Munich 42
Boulder 40
Bremen 40
Zurich 40
Nanchang 38
Lagos 37
Vienna 36
Redondo Beach 35
Lancaster 33
Redwood City 33
Frankfurt am Main 32
Marseille 32
Ogden 32
Brussels 31
Hyderabad 31
Kocaeli 29
Sacile 29
Kunming 27
North York 27
San Diego 27
Paris 26
Shenyang 26
Düsseldorf 24
Kochi 24
Fuzhou 23
Pune 23
Dakar 22
Guangzhou 22
Toronto 22
Da Nang 20
Hebei 19
Rio de Janeiro 19
Grafing 18
Baghdad 17
Jiaxing 17
Tianjin 17
Dhaka 16
Orem 16
Brooklyn 15
Falls Church 15
Haiphong 15
Philadelphia 15
San Francisco 15
Verona 15
Belo Horizonte 14
Changsha 14
Hangzhou 14
Totale 15.803
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 403
1,2,3-Triazole[4,5-d]pyridazines II. New Derivatives Tested on the Adenosine Receptors 356
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 350
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 337
1,2,3 Triazolo[1,2-a]benzotriazoles or 2,3-Benzo-1,3a,6,6a-Tetraazapentalenes 334
An 1,2,3-Triazole Derivative Bioisoster of a Potent in Vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 330
1,2,3-triazolo [4,5-d] pyridazines-V. Preparation and adenosine receptor binding of new 4-amino derivatives. 324
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 301
1,2,3-TRIAZOLO[4,5-e]-1,2,4-TRIAZOLO[3,4-c]PYRIMIDINES 296
N(6)-SUBSTITUTED 2-PHENYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR - A COMPARISON WITH 2-N-BUTYL ANALOGOUS DERIVATIVES .5. 293
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 292
N(6)-SUBSTITUTED 2-N-BUTYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR .4. 289
1,2,3-TRIAZOLE[4,5-D]PYRIDAZINES .3. SYNTHESIS OF NEW 4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARD ADENOSINE RECEPTORS 286
1,2,3-Triazolo[4,5-d]-1,2,4-triazolo[4,3-b]pyridazines 281
1,2,3-Triazole[4,5-d]pyridazines IV. Preparation and Adenosine Receptor Binding of New 4-and /or 7-Aminoderivatives 280
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 272
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 266
1,2,3-Triazolodiazepine I. Preparation and Benzodiazepine Receptor Binding of 1-Benzyl and 1-Phenethyl-1,2,3-Triazolo[4,5-d][1,4]diazepines 263
1,2,3-TRIAZOLO[4,5-D]PYRIDAZINES. PART VI. NEW 1-SUBSTITUTED-4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARDS A1 AND A2 ADENOSINE RECEPTORS 263
N(6)-Substituted 2-n-Butyl-9-Benzyl-8-Azaadenines. Affinity for Adenosine A1 and A2 Receptors. IV 260
1,2,3-triazolo[4,5-d]pyridazines - Part VI. New 1-substituted-4-amino derivatives and their affinity towards A(1) and A(2A) adenosine receptors 258
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 253
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 252
N-(9-Benzyl-2-phenyl-9H-8azapurin-6-yl)-amides: A new class of A1 adenosine receptor ligands 250
N(6)CYCLOALKYL-2-PHENYL-3-DEAZA-8-AZAADENINES: A NEW CLASS OF A1ADENOSINE RECEPTOR LIGANDS. A COMPARISON WITH THE CORRESPONDING ADENINES AND 8-AZAADENINES 244
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 237
N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives.5. 234
"One Pot" Synthesis of 2-Substituted 9-(2'-Hydroxy-3'-aminopropyl)-8-azahypoxanthines and 8-Azaadenines [5-Substituted 3-(2'-Hydroxy-3'-aminopropyl)-7-amino and 7-hyroxy- 3H-1,2,3-triazolo[4,5-d]pyrimidines] 233
N(9)-substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines 230
Synthesis of New 3-Benzyl-5-Phenyl-7-Alkylaminothiazolo[4,5-d]pyrimidine-2(3H)-Thiones.) 227
N(6) or N(9) Substituted 2-Phenyl-8-Azaadenines: Affinity for A1 Adenosine Receptors. VII 227
N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors. 226
Adenosine A1 modulators: a patent update (2008 to present) 222
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 220
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 220
2-Fenyl-9-benzyl-6-arylamido-8-azapurines: new potent ligands of adenosine receptors 219
8-Azapurine nucleus: a versatile scaffold for different targets 210
A QSAR study of A1adenosine receptor antagonists by a new neural network model 209
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 204
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 201
New amido derivatives as potential BKCa potassium channel activators. XI 193
Studies on 1,2,3-Triazole Derivatives as in vitro Inhibitors of Prostaglandine Synthesis 190
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 190
Xanthine Oxidase (XO). 4(5)-Aminosubstituted-5(4)-Carboxyamido-1H-1,2,3-Triazoles: a New Class of Monocyclic Triazole Inhibitors 189
Interaction of an improved model of human A1 adenosine receptor with ligands 188
In vitro Inhibitors of Prostaglandin Synthesis: (p-Thiosubstituted)-Benzyl Nitrogen Heterocycles 187
QSAR Studies on Purine and 2,3-Dihydropurine Analogues as Antitubercular Agents 185
1,2,3-Trizoles[4,5-d]piridazines. Analogues of Prostaglandin Synthesis Inhibitors 185
Xanthine Oxidase Inhibition: Effect of a Linear Carboalkoxy Substituent on C(2) of the Nucleus of 8-Azahypoxanthine 181
QSAR study on purine and 2,3-dihydropurine analogues as antitubercular agents 181
QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists 181
A 3D model of human A1 adenosine receptor. An evaluation of the binding free energy with ligands 180
Antimicrobial properties of flavonoids. 179
Studies on Specific Inhibition of Benzodiazepine Receptor Binding by Some C-Benzoyl-1,2,3-triazole Derivatives 179
XANTHINE-OXIDASE (XO) - RELATIVE CONFIGURATION OF COMPLEXES FORMED BY THE ENZYME, 2-N-ALKYL-HYPOXANTHINE OR 8-N-ALKYL-HYPOXANTHINE AND 2-N-ALKYL-8-AZAHYPOXANTHINES .12. 178
Synthesis of N(6)-Substituted 2-Phenyl-8-Azaadenosines. Their Affinity for Adenosine A1 and A2 Receptors: a Comparison with the Corresponding 2-Phenyl-9-Benzyl-8-Azaadenines. 178
3-[(2-Ethoxyphenoxy)methyl]piperidine derivatives. Synthesis and antidepressant activity 178
Evaluation of the Quantitative Contribution of a Phenyl Group on C(2) of 8-Azaadenosine to the Binding with Adenosine Deaminase: a New Synthesis of 8-Azaadenosine. XI. 177
New 4-(Benzotriazol-1-yl)-1,2,3-triazole derivatives 176
Introduction of a hydroxy function on N6 8-azaadenine substituents to improve the solubility and the effectiveness of antagonists towards A1 adenosine receptors 176
An initial comparison of the content of bitter substances in Cynara Scolymus L. plants obtained from rooted of shoots and micropropagation 174
Evaluation of new synthesized “adenine derivatives” molecules as cytokinin-like compounds . 174
Modification of the 1,2,3-Triazole Ring Present in an Effective in vitro Inhibitor of Prostaglandin Synthesis 172
Structure-Activity Studies on a 1,2,3-Triazole Derivative, a Potent in vitro Inhibitor of Prostaglandin Synthesys: the Role of the Heterocyclic Ring 172
Bioisosterism, enantioselectivity and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: different binding modes to A1 adenosine receptors 172
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 172
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 170
Synthesis of New 2-Substituted 9-?-D-Ribofuranosyl-8-Azahypoxanthine 165
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 164
Alimentazione e qualità della vita 162
Xanthine Oxidase (XO): Relative Configuration of Complexes Formed by the Enzyme, 2- or 8-n-Alkyl-hypoxanthines and 2-n-Alkyl-8-azahypoxanthines. XII 159
Synthesis of New 1,2,3-triazolo[1,2-a]benzotriazole derivatives or substituted 2,3-benzo-1,3a,6,6a-tetraazapentalenes. II” 159
ERYTHRO AND THREO 2-HYDROXYNONYL SUBSTITUTED 2-PHENYLADENINES AND 2-PHENYL-8-AZAADENINES: LIGANDS FOR A1 ADENOSINE RECEPTORS AND ADENOSINE DEAMINASE 159
TRIAZOLYLBENZIMIDAZOLTHIONES AND DERIVATIVES OF THE NEW 1,2,3-TRIAZOLO[1,5-A][1,3,5]BENZOTRIAZEPINE HETEROCYCLE 159
An 1,2,3,Triazole Derivatives Bioisoster of a Potent in vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 158
Synthesis and functional evaluation of Adenosine A2A receptor ligand 158
Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands 155
New Chiral Inhibitors of Induced Platelet Aggregation: the Enantiomeric Specificity of (R)- and (S)-Methyl and Ethyl Esters of 1-{p-[(1-Hydroxycarbonyl)-ethyloxy]-benzyl}-1H-1,2,3-triazole as a Tool for Determining their Biological Target. 154
A Method for the Synthesis of Racemic and Optically Active 2-Substituted 9-(2',3'-Dihidroxypropyl)-8-Azahypoxanthines and 8-Azaadenines 153
SOME STRUCTURAL CHANGES ON TRIAZOLYL-BENZOTRIAZOLES AND TRIAZOLYL-BENZIMIDAZOLONES AS POTENTIAL POTASSIUM CHANNEL ACTIVATORS. III 151
2-ALKYLOXYALKYLTHIOHYPOXANTHINES AS NEW POTENT INHIBITORS OF XANTHINE OXIDASE 151
THERAPEUTIC POTENTIAL OF A1 ADENOSINE RECEPTOR LIGANDS: A SURVEY OF RECENT PATENT LITERATURE 150
Xanthine Oxidase (XO). Synthesis of 4(5)-Carbxyamido-5(4)-aminoalkanoyl)amino-1,2,3-triazoles and Their Cyclization to 8-Azahypoxanthines. Evaluation for Inhibition of XO. 149
Synthesis and ADA Inhibitory Activity of New 2-Aryl-8-Azaadenosines 148
Interactions of an improved model of the the Human A1 Adenosine Receptor with Ligands 145
NEW 5-SUBSTITUTED-1-(2-HYDROXYBENZOYL)-BENZOTRIAZOLES, POTASSIUM CHANNELS ACTIVATORS. IV 145
NEW 1,2,3-TRIAZOLO[4,5-E]1,2,3-TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES.II 145
Steroeselectivity as an evidence for a double insertion of Antagonists within A1 Adenosine Receptors 144
Synthesis and Biological Evaluation of New Imidazole, Pyrimidine and Purine Derivatives and Analogs as Inhibitors of Xanthine Oxidase 143
THE NEW DEGREE IN TECHICHE ERBORISTICHE (HERBAL TECHNOLOGY) 142
A 3D Model of the Human A1 Adenosine Receptor. An Evaluation of the Binding Free-Energy with Ligands 139
SUBSTITUTED 1,2,3-TRIAZOLO[1,5-A]QUINAZOLINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS 137
NEW N6-OR N(9)-HYDROXYALKYL SUBSTITUTED 8-AZAADENINES OR ADENINES AS AFFECTIVE A1 ADENOSINE RECEPTOR LIGANDS 136
Synthesis of analogs of (±)-EHNA as potent inhibitors of ADA 135
Chemistry of the Dihydrothiazine Ring Moiety of Cephalosporins. A Route to 3-Formoxymethyl-3-Cephem Derivatives 134
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 134
Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX 132
Bioisosterism, Enantioselectivity and Molecular Modelling of New Effective Substituted 2-Phenyl Adenines and 8-AZA Analogues. Different Binding Modes to A1 Adenosine Receptors 129
1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI. 129
New amino derivatives of 1,2,3-triazolo[4,5-D]pyrimidines and their affinity towards A1 and A2A adenosune receptors 129
Totale 20.361
Categoria #
all - tutte 57.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.324 0 0 20 110 259 198 15 100 87 14 91 430
2022/20231.873 254 240 118 208 217 239 30 138 304 7 101 17
2023/20242.134 319 238 365 218 313 224 29 56 25 58 44 245
2024/20254.036 46 146 41 212 429 407 286 229 355 455 528 902
2025/20264.498 481 674 518 258 407 395 845 178 230 322 122 68
2026/2027982 147 364 471 0 0 0 0 0 0 0 0 0
Totale 22.295